IRWD— IRONWOOD PHARMACEUTICALS INC

MaterialsPharmaceutical Preparations$669M mkt cap

Metric	FY2025	FY2024	FY2023	FY2022
Total revenues	$296.2M-15.7%	$351.4M-20.6%	$442.7M+7.8%	$410.6M
Research and development	$95.1M-14.6%	$111.4M-4.0%	$116.1M+162.3%	$44.3M
Selling, general and administrative	$82.3M-43.0%	$144.3M-8.9%	$158.3M+36.5%	$116.0M
Restructuring, net	$20.3M+681.2%	$2.6M-85.8%	$18.3M	—
Total costs and expenses	$197.6M-23.5%	$258.3M-81.4%	$1.39B+766.2%	$160.3M
Income from operations	$98.5M+5.8%	$93.1M+109.8%	-$945.4M-477.7%	$250.3M
Interest expense and other financing costs	-$32.7M+0.9%	-$33.0M-52.7%	-$21.6M-184.7%	-$7.6M
Interest and investment income	$4.1M-8.8%	$4.5M-76.4%	$19.0M+99.7%	$9.5M
Other	$193K-69.8%	$640K	—	—
Other income (expense), net	-$28.5M-2.0%	-$27.9M-958.2%	-$2.6M-226.6%	$2.1M
Income before income taxes	$70.0M+7.4%	$65.2M+106.9%	-$948.1M-475.6%	$252.4M
Income tax expense	-$46.0M+28.5%	-$64.3M+23.0%	-$83.5M-7.9%	-$77.4M
Net income	$24.0M+2629.2%	$880K+100.1%	-$1.00B-672.5%	$175.1M
Net income per share - basic (in dollars per share)	$150.00+1400.0%	$10.00+100.2%	-$6450.00-670.8%	$1130.00
Net income per share - diluted (in dollars per share)	$150.00+1400.0%	$10.00+100.2%	-$6450.00-771.9%	$960.00
Weighted average shares used in computing net income per share - basic (in shares)	$161842000.00+1.7%	$159083000.00+2.3%	$155435000.00+0.7%	$154366000.00
Weighted average shares used in computing net income per share - diluted (in shares)	$162983000.00+1.8%	$160084000.00+3.0%	$155435000.00-16.6%	$186312000.00

Source: SEC EDGAR XBRL. % change vs prior period shown where available.

Pro feature

Unlock 13 more years of annual history and full quarterly detail on Pro.

Source: SEC EDGAR 10-K and 10-Q filings. Last 4 years annual and quarterly free, full history (up to 20 years) on Pro.